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Abstract
Pathogen-activated and damage-associated molecular patterns activate the inflammasome in macrophages. We report that
mouse macrophages release IL-1b while co-incubated with pro-B (Ba/F3) cells dying, as a result of IL-3 withdrawal, by
apoptosis with autophagy, but not when they are co-incubated with living, apoptotic, necrotic or necrostatin-1 treated cells.
NALP3-deficient macrophages display reduced IL-1b secretion, which is also inhibited in macrophages deficient in caspase-1
or pre-treated with its inhibitor. This finding demonstrates that the inflammasome is activated during phagocytosis of dying
autophagic cells. We show that activation of NALP3 depends on phagocytosis of dying cells, ATP release through pannexin-
1 channels of dying autophagic cells, P2X7 purinergic receptor activation, and on consequent potassium efflux. Dying
autophagic Ba/F3 cells injected intraperitoneally in mice recruit neutrophils and thereby induce acute inflammation. These
findings demonstrate that NALP3 performs key upstream functions in inflammasome activation in mouse macrophages
engulfing dying autophagic cells, and that these functions lead to pro-inflammatory responses.
Citation: Ayna G, Krysko DV, Kaczmarek A, Petrovski G, Vandenabeele P, et al. (2012) ATP Release from Dying Autophagic Cells and Their Phagocytosis Are Crucial
for Inflammasome Activation in Macrophages. PLoS ONE 7(6): e40069. doi:10.1371/journal.pone.0040069
Editor: Jean Kanellopoulos, University Paris Sud, France
Received January 6, 2012; Accepted May 31, 2012; Published June 29, 2012
Copyright:  2012 Ayna et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work has been supported by grants from the Hungarian Scientific Research Fund (OTKA NI 67877, K 61868), TAMOP-4.2.2-08/1/2008-0015 and
TA´MOP 4.2.1./B-09/1/KONV-2010-0007 project implemented through the New Hungary Development Plan, co-financed by the European Social Fund, an ETT
(Ege´szse´gu¨gyi Tudoma´nyos Tana´cs) grant from the Hungarian Ministry of Health, EU MRTNCT-2006-036032 and MRTN-CT 2006-035624, Fund for Scientific
Research Flanders (FWO [Het Fonds Wetenschappelijk Onderzoek - Vlaanderen]-Vlaanderen, 3G072810 to D.V.K.) and by an individual research grant from FWO-
Vlaanderen (31507110 to D.V.K.). D.V.K. is a postdoctoral fellow and A.K. is a doctoral fellow, both paid by fellowships from FWO-Vlaanderen. Peter Vandenabeele’s
group is supported by VIB, Ghent University (GROUP-ID consortium of the UGent MRP initiative), FWO-Vlaanderen (G.0875.11 and G.0973.11), Federal Research
Program (IAP 6/18), European Research Program FP6 ApopTrain (MRTN-CT-035624), FP7 Apo-Sys 200767, and the Euregional PACTII (Euregional PACT II -
Euregional Platform for Advancing Cancer Treatment II ). P.V. holds a Methusalem grant (BOF09/01M00709) from the Flemish Government. The funders had no
role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: fesus@med.unideb.hu
Introduction
Different types of dying cells, including apoptotic cells, are
removed from tissues to prevent immune reactions and maintain
tissue homeostasis [1,2,3,4]. Inability to recognize and remove
dead cells can lead to diseases such as autoimmune disorders,
cystic fibrosis, and asthma [5,6]. The anti-inflammatory features of
apoptotic cells resulting from surface exposure of anti-inflamma-
tory molecules such as phosphatidylserine have been known for
some time [7,8]. These anti-inflammatory molecules are among
the apoptotic cell-associated molecular patterns (ACAMPs) [9].
However, during the last couple of years it has become clear that
apoptotic cells under certain conditions can also be immunogenic
due to exposure/release of damage-associated molecular patterns
(DAMPs) [10,11]. A ‘‘danger theory’’ proposed by Matzinger
states that the immune system can discriminate not only self from
non-self but also dangerous signals (such as DAMPs) from
innocuous ones [12]. DAMPs can be secreted, released and/or
exposed on the outer leaflet of the plasma membrane and can
provide several kinds of signals: ‘find-me’ (chemotactic), ‘eat-me’
(phagocytic), and ‘activation’ (immune stimulatory) factors [13].
DAMPs are recognized by membrane-bound or cytoplasmic
pattern recognition receptors (PRRs), which include Toll-like
receptors (TLRs), NOD-like receptors (NLRs), RIG-I-like recep-
tors (RLRs) and purinergic receptors [14,15]. Interestingly, cell
death associated with autophagy can also provide immunogenic
signals. It was recently shown that cross-priming of antigen-specific
CD8+ T cells is facilitated when antigen donor cells undergo
autophagy before dying by apoptosis [16]. Phagocytosis of MCF-7
cells dying by autophagy leads to inflammasome activation and IL-
1b production in human monocyte derived macrophages [17,18],
but the autophagic dying cells can still inhibit the production of
lipopolysaccharide (LPS)-induced pro-inflammatory cytokines
(such as TNF-a, IL-6 and IL-8). Autophagy contributes to making
apoptotic cancer cells immunogenic [19] and thereby capable of
activating the inflammasome in dendritic cells [20]. However, the
mechanism of inflammasome activation by dying autophagic cells
is still not defined entirely.
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IL-1b production is a tightly controlled process playing a pivotal
role in inflammation and during recruitment of neutrophils into
tissues [21]. A two-signal model has been proposed to explain the
regulation of IL-1b production. First, pro-IL-1b is synthesized and
accumulates in response to signaling through the TLRs, which
usually activate the transcription factor known as nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-kB) and the
activity of the IL-1b promoter [22]. A secondary stimulus (such as
adenosine triphosphate (ATP) or DAMPs) induces the activation
of cytoplasmic receptors. These nucleotide binding domain
(NOD)-like receptors (e.g. NALP3) are normally auto-repressed,
but their stimulation results in assembly of an inflammasome
complex that recruits apoptosis-associated speck-like protein
containing a caspase recruitment domain (ASC), which further
recruits pro-caspase-1. Upon auto-cleavage of pro-caspase-1, its
mature form cleaves pro-IL-1b and the cleaved IL-1b is secreted
[23]. How NOD-like receptors sense the particular inducer and
lead to secretion of IL-1b from macrophages has not been clarified
in detail [24]. A common trigger of NALP3 inflammasome
activation is a low intracellular potassium (K+) concentration,
which occurs, for example, upon stimulation of macrophages by
the ATP released during inflammation or tumor growth [19]; this
ATP acts on purinergic receptor P2X7 [25,26,27,28]. Opening of
pannexin-1 channels, which has also been implicated in activation
of the inflammasome pathway, results in cytosolic recognition of
bacterial products in macrophages [29].
In the present work we have extended previous studies by
gaining more insight into the mechanism of inflammasome
activation by dying autophagic cells in various types of macro-
phages. We report that upon IL-3 withdrawal, pro-B lymphoma
cells (Ba/F3) dying by apoptosis associated with autophagy
become pro-inflammatory by inducing NALP3 inflammasome
activation in the mouse macrophages engulfing them. We
identified several elements of the upstream mechanisms of NALP3
activation, including secretion of ATP from the dying autophagic
cells through pannexin-1 channels, activation of P2X7 receptors,
and K+ efflux from the macrophages. We also show that pro-
inflammatory dying autophagic cells recruit neutrophils in vivo and
thereby induce an acute inflammatory response.
Results
During IL-3 Deprivation, Ba/F3 Cells Undergo
Pronounced Autophagy Followed by Apoptosis
Withdrawal of growth factors triggers both autophagy and
apoptosis in Ba/F3 cells [30]. By using anti-LC3 immunostaining
and acridine orange staining, we observed that 6 h of IL-3
depletion increased the numbers of autophagolysosomes in Ba/F3
cells (Figure 1A). Western blot analysis showed increased level of
LC3-II (a molecular marker of autophagosome formation) relative
to controls (Figure 1B). To determine whether IL-3 withdrawal
causes upregulation of autophagosome formation (increased
autophagic flux) or blockage of autophagic degradation, we
treated the cells with the lysosomal inhibitor, chloroquine (CQ),
which prevents fusion of autophagosomes with lysosomes [31,32].
CQ treatment led to highly elevated LC3-II protein content in IL-
3 depleted cells, demonstrating that withdrawal of the growth
factor resulted in increased autophagic flux but not blockade of
autophagy (Figure 1B). In the presence of IL-3, CQ treatment also
led high LC3-II content indicating ongoing autophagic flux. It can
not be excluded that since the cell suspensions are heterogeneous
and the method is not sensitive enough there might be cells in
which LC3-II degradation was blocked.
After 6 h of IL-3 withdrawal, ,20% of the cells were positive
for phosphatidylserine (PS)+ and negative for propidium iodide
(PI)-, and ,4% of them were PS+/PI+ (Figure 1C). This indicated
initiation of apoptosis and is in accordance with findings showing
caspase-3 processing (Figure 1D) after 6 h of IL-3 depletion [30].
When Ba/F3 cells were treated with CQ in the presence of IL-3,
accumulation of autophagosomes did not lead to a significant
increase in cell death, but the combined effect of IL-3 depletion
and addition of the lysosomal inhibitor induced more cell death
than IL-3 alone (Figure 1C).
Apoptotic and necrotic cells die without increased signs
of autophagy
Ba/F3 cells were treated with various concentrations of
doxorubicin in the presence of IL-3 for 16 h. According to our
immunoblotting results, induction of apoptosis in Ba/F3 cells by
10 mM doxorubicin did increase their autophagic activity
(Figure 2A). At lower doses of doxorubicin autophagy was
increased but only a much lower percentage of cells died
(Figure 2A). Necrotic Ba/F3 cells did not induce elevated
autophagic activity neither (Figure 2B).
Dying Autophagic Cells Induce Resident Macrophages to
Release IL-1b, but Live, Apoptotic, Necrotic or
Necrostatin-1-treated Cells do not
Co-incubation assays were conducted to observe the response of
macrophages to the presence of Ba/F3 cells. Non-primed resident
peritoneal macrophages were unresponsive to dying autophagic
Ba/F3 cells and released no IL-1b (data not shown) while LPS
priming alone induced a basal levels of IL-1b secretion. When the
macrophages were primed with ultrapure LPS to stimulate
synthesis of pro-IL-1b before co-incubation with dying autophagic
cells, secretion of mature IL-1b by macrophages was significantly
increased (Figure 3A). IL-1b was released in even larger amounts
when dying autophagic cells were treated with the lysosomal
inhibitor (CQ) before their co-incubation with the macrophages
(Figure 3A). Co-incubation of macrophages with live cells or with
apoptotic (induced by 10 mM doxorubicin) or necrotic cells did not
increase IL-1b secretion (Figure 3A). Thioglycollate-elicited
macrophages (Figure 3B) and bone marrow derived macrophages
(BMDMs) (data now shown) also released significantly more IL-1b
than controls after their co-incubation with dying autophagic cells.
Dying autophagic Ba/F3 cells by themselves did not produce IL-
1b (Figure 3A), and culture medium used for Ba/F3 (with IL-3 and
fetal bovine serum) did not induce IL-1b secretion in macro-
phages.
To determine whether autophagy in the phagocytosis target
cells is required for IL-1b release from macrophages, we inhibited
autophagy in Ba/F3 cells by the inhibitor of type III phosphoi-
nositide 3-kinase (PI3K), 3-methyladenine (3-MA). Indeed, this
inhibition decreased the pro-inflammatory response in the
macrophages (Figure 4A). To exclude the involvement of the
necroptotic cell death pathway, we treated the dying autophagic
cells with the necroptosis inhibitor necrostatin-1 [2] and found that
it could not prevent IL-1b release from resident macrophages
exposed to dying autophagic cells (Figure 4A).
Engulfment of Dying Autophagic Cells by Resident
Macrophages is Required for IL-1b Release
Resident peritoneal macrophages engulfed 30% of dying
autophagic cells and up to 43% of CQ-treated dying autophagic
cells, in contrast to 12% of living cells and up to 27% of CQ-
treated living cells during 2 h of co-incubation (data not shown).
Inflammasome Activation by Dying Autophagic Cells
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To investigate whether the uptake of dying autophagic cells by
macrophages is important for IL-1b release, we pre-treated
macrophages with cytochalasin D (CytD) to inhibit phagocytosis
[33]. Indeed, CytD inhibited phagocytosis of dying autophagic
cells (Figure 4B) and also significantly reduced IL-1b release. This
indicates that the increased IL-1b secretion was dependent on the
uptake of dying autophagic cells by macrophages (Figure 4C).
Incubation of primed macrophages in conditioned medium (CM)
obtained from cultures of Ba/F3 cells depleted of IL-3 for 6 h did
not result in IL-1b release (Figure 4C).
Dying Autophagic Cells Induce Caspase-1 Dependent
NALP3 Inflammasome Activation in Thioglycollate-
elicited Peritoneal Macrophages
To check whether caspase-1 activation is responsible for the
inflammatory response, we co-incubated caspase-1 knockout
mouse macrophages with dying autophagic Ba/F3 cells. Cas-
pase-1 deficient macrophages released significantly less IL-1b than
wild type macrophages (Figure 5A). We confirmed this finding by
using a specific caspase-1 inhibitor which also reduced IL-1b
secretion (Z-YVAD-fmk, Figure 5B). Furthermore, macrophages
isolated from NALP3 knockout mice had decreased response to
dying autophagic cells, indicating that the NALP3 inflammasome
can be the mediator of caspase-1 activation and IL-1b secretion
(Figure 5C). There was no difference in the phagocytic capacity of
wild type and NALP3 knockout macrophages (Figure 5D).
Upstream Mechanisms of NALP3 Inflammasome
Activation in Macrophages Engulfing Dying Autophagic
Cells
We sought to identify the signaling pathway involved in NALP3
inflammasome activation triggered by engulfment of dying
autophagic cells. We first investigated whether potassium efflux,
a general inducer of NALP3 inflammasome activation [34], is
required for induction of IL-1b release from mouse peritoneal
macrophages by dying autophagic Ba/F3 cells. Blocking K+ efflux
Figure 1. Autophagy is induced in apoptotic Ba/F3 cells by IL-3 depletion. Ba/F3 cells were kept without IL-3 for 6 h (dying AU). (A) Both
living and dying autophagic Ba/F3 cells were stained with anti-LC3 antibody or acridine orange stain to demonstrate increased autophagosome
formation. Arrows represent the increased autophagy with IL-3 depletion. Scale bars are 10 mm. (B) Proteins in western blots of samples from dying
autophagic cells were detected with anti-LC3 antibody. Chloroquine (CQ) was used as lysosomal inhibitor. The right panel presents the quantification
of the western blot. Data represent the mean6 SEM of 13, 19, 5 and 6 independent experiments for IL-3+, IL-3-, IL-3+CQ+ and IL-3-CQ+, respectively.
(C) Cell death was quantified by flow cytometric analysis of dying autophagic cells by using Annexin-V-FITC/PI staining. Data represent the mean 6
SEM of 7, 10, 3 and 9 independent experiments for IL-3+, IL-32, IL-3+CQ+, IL-32CQ+, respectively. PS: Phosphatidylserine, PI: Propidium iodide (D)
Proteins obtained from dying autophagic cells were detected with caspase-3 antibody. Anti-actin poyclonal antibody was used to show that equal
amounts of proteins were loaded in western blots. For simplicity, parts from the same western blots are shown separately in parts B and D. (*p,0.05,
**p,0.01, ***p,0.001, ****p,0.0001).
doi:10.1371/journal.pone.0040069.g001
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by including potassium in the medium led to decreased of IL-1b
release from both resident peritoneal (Figure 6A) and thioglycol-
late-elicited peritoneal macrophages (data not shown).
The next question was whether ATP released during engulf-
ment of dying autophagic cells contributes to inflammasome
activation. A substantial amount of ATP (400–500 nM) was
detected in the conditioned medium obtained after co-incubation
of macrophages with dying autophagic cells in the absence of
serum (Figure 6B). The hydrolysis of secreted ATP by apyrase
during phagocytosis led to the decrease of IL-1b release
(Figure 6B). These data indicate that released ATP contributed
to the pro-inflammatory induction of macrophages. To further
explore whether activation of the purinergic receptor P2X7 by
released ATP is essential for inflammasome activation, we blocked
the purinergic receptors by using 1-[N,O-bis(5-isoquinolinesulfo-
nyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine (KN-62) [35]. IL-1b
release was inhibited by KN-62, indicating that NALP3 inflam-
masome activation was dependent on stimulation of the P2X7
receptor (Figure 6C).
We then analyzed the contribution of the pannexin-1 channel to
inflammasome activation by using carbenoxolone (CBX), a specific
pannexin-1 channel inhibitor [36], to block the channel’s activity
during co-incubation of dying autophagic cells with macrophages.
CBX treatment inhibited IL-1b release from resident macro-
phages (Figure 6D). Furthermore, CBX also blocked ATP
secretion, showing that ATP was released through these channels
(Figure 6D). To identify the source of the released ATP, we
measured ATP released in the CM by dying autophagic cells
cultured alone. We found that it was in the 8-10 mM range, and
that its release could be inhibited by CBX (Figure 6E). Next, we
checked whether living, necrotic and apoptotic Ba/F3 cells alone
release ATP. We found that living cells did not release ATP, but
necrotic and apoptotic Ba/F3 cells (10 mM doxorubicin) released
ATP in the 1 mM range.
We also observed that when dying autophagic cells were
removed from wells in which a co-incubation experiment has been
conducted (after 2 h), macrophages did not release IL-1b any
longer (data not shown), which indicates that ATP was released
from dying cells but not from macrophages.
Figure 2. Apoptotic and necrotic Ba/F3 cells do not show autophagic activity. (A) Ba/F3 cells were treated with different doses of
doxorubicin in the presence of IL-3 for 16 h. Immunoblotting with anti-LC3 antibody was done to detect LC3 protein in cells. Ba/F3 cells which were
not treated with doxorubicin in IL-3 containing medium were used as control for the experiment. (B) Necrosis in Ba/F3 cells was induced by freeze-
thaw. Anti-actin polyclonal antibody was used to show that equal amount of proteins were loaded. For simplicity, parts from the same western blots
are shown separately. Cell death was checked by flow cytometric analysis of dying cells by using Annexin-V-FITC/PI staining. Relevant controls
(autoflourescent and Annexin-V-FITC positive cells) are also included in the figure.
doi:10.1371/journal.pone.0040069.g002
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Dying Autophagic Ba/F3 Cells Recruit Neutrophils into
the Peritoneal Cavity as a Sign of Acute Inflammatory
Response
In our attempt to support our in vitro results showing that dying
autophagic Ba/F3 cells are pro-inflammatory, we injected dying
autophagic cells into the peritoneum of mice. We observed influx
of neutrophils into the peritoneal cavity, indicating that the dying
autophagic cells induced an acute inflammatory response in vivo as
well (Figure 7). Living, necrotic and apoptotic Ba/F3 cells (10 mM
doxorubicin) were also injected i.p. Apoptotic cells recruited
neutrophils, monocytes and eosinophils, but they led to the
decrease of macrophages resident in the peritoneum. Living,
autophagic and necrotic cells also diminished the number of
macrophages. Necrotic and living cells could not induce neutro-
phil influx. Only necrotic and apoptotic cells recruited eosinophils
into the peritoneal cavity.
Dying Autophagic Cells Inhibit Crude LPS-induced IL-6
Release
Although the dying autophagic Ba/F3 cells could induce a pro-
inflammatory response in macrophages and provoked them to
secrete IL-1b, they could also inhibit the LPS-induced pro-
inflammatory response as measured by IL-6 release (Figure 8).
Discussion
We have shown that mouse macrophages display a pro-
inflammatory response to Ba/F3 lymphoma cells dying by
apoptosis associated with autophagy in response to IL-3
withdrawal, but not when they are exposed to living, apoptotic,
necrotic or necrostatin-1-treated cells. The NALP3 inflammasome
and caspase-1 were activated in the macrophages while they were
taking up dying autophagic cells, leading to IL-1b release from the
macrophages. Activation of NALP3 was dependent on the uptake
of dying cells, ATP release through the pannexin-1 channel (P2X7
purinergic receptor), and K+ efflux. Injection of dying autophagic
Figure 3. Resident peritoneal macrophages release IL-1b while engulfing dying autophagic Ba/F3 cells. (A) IL-3-depleted cells, live cells,
apoptotic cells (treated with 10 mM doxorubicin), and necrotic Ba/F3 cells were co-incubated with primed resident macrophages. As a control
condition, IL-1b was quantified from supernatant of only dying autophagic Ba/F3 cells in order to analyze if they secrete IL-1b by themselves. ATP,
which is a stimulus for the inflammasome activation, was used as a positive control. (B) Primed thioglycollate-elicited macrophages were co-
incubated with IL-3-depleted dying autophagic cells. Primed macrophages (control) but not co-incubated with any type of Ba/F3 cells. Unpaired non-
bias two-tailed student t-test was used for statistical analysis in part B. Data represent the mean6 SEM of three and four independent experiments in
parts A and B, respectively; all experiments were performed in triplicates. (*p,0.05, **p,0.01, ****p,0.0001).
doi:10.1371/journal.pone.0040069.g003
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cells intraperitoneally induced an acute inflammation by recruiting
neutrophils.
Increased autophagy after IL-3 depletion was demonstrated in
dying Ba/F3 cells by acridine orange staining and punctuate
pattern which represents autophagosomes detected with anti-LC3
antibody, as well as by the increased level of LC3-II. These data
are in line with previously published results obtained with Ba/F3
cells, which showed that IL-3 dependent murine Ba/F3 pro-B cells
respond to growth factor withdrawal by inducing autophagy as
a survival mechanism [30]. Moreover, it has been shown that
increased autophagic activity sensitizes Ba/F3 cells for apoptosis
through caspase-dependent generation of beclin-1 cleavage
fragments and degradation of type III PI3K [30]. IL-3 withdrawal
leads Ba/F3 cells to stay in G0/G1 phase [37] and the most
apoptosis-resistant Ba/F3 cells can use autophagy-derived nu-
trients under growth factor depletion. However, autophagic
activity can be a sensitizer for these cells and they become more
prone to die by apoptosis [38]. We wanted to clarify that IL-3
depletion leads to upregulation of autophagy instead of blockage of
autophagy (degradation block). Since LC3-II is also degraded by
autophagy increased amount of LC3-II protein by itself at a certain
time can not represent properly the dynamics of autophagy and it
is recommended to observe LC3 levels following lysosomal
inhibition [31,32]. We have treated our IL-3 depleted/non-
depleted Ba/F3 cells with lysosomal inhibitor (CQ) and found that
blocking the fusion of autophagosomes with lysosomes by CQ
Figure 4. Uptake of dying autophagic cells and autophagic features of dying cells are required for macrophages to release IL-1b. (A)
Primed resident macrophages were co-incubated with Ba/F3 cells that were IL-3-depleted, or IL-3-depleted and also pretreated with 3-methyladenine
(3-MA) or necrostatin-1. Cell death was checked by flow cytometric analysis of dying autophagic cells by using Annexin-V-FITC/PI staining. For
simplicity, parts of the same western blot are shown separately. (B, C) CMTMR-stained macrophages were treated with cytochalasin D (cytD) to
inhibit phagocytosis, and cytD treated/non-treated macrophages were co-incubated with CFDA-stained dying autophagic Ba/F3 cells. R2 is the
region which shows both the upper left quadrant (macrophages which do not engulf dying cells) and upper right quadrant (macrophages which
engulf dying cells). The cells out of R2 region is also shown in the figure. The macrophages were also co-incubated with the conditioned medium
(CM) from dying autophagic cells. In parts A and C, control cells are macrophages, which were primed but not co-incubated with any type of Ba/F3
cells. Data represent the mean 6 SEM of two independent experiments; all experiments were performed in triplicates, (***p,0.001).
doi:10.1371/journal.pone.0040069.g004
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treatment led to accumulation of LC3-II, which further proved
that the increased autophagy after IL-3 withdrawal was due to up-
regulation of autophagosome formation (autophagic flux) and not
to lysosomal blockage. According to our results, there is a basal
autophagy rate in Ba/F3 cells. When we added CQ to living cells
(IL-3+), LC3-II accumulated due to blocking of the basal
autophagic activity, but there was no increase in cell death
(Figure 1B, 1C). On the other hand, IL-3 depletion led to
significant elevation of autophagic activity above the basal level
and to cell death. We have also shown that blockage of the
lysosomal pathway by CQ treatment increases the percentage of
cell death when the cells are depleted of IL-3.
We show that uptake of dying autophagic Ba/F3 cells by
different types of murine macrophages activates the NALP3
inflammasome pathway. This is in line with our previous findings
from experiments in which we used human MCF-7 cells dying by
autophagy as phagocytosis targets of monocyte derived macro-
phages [17,39]. Despite the similarities between our previous and
current studies, important differences and new aspects have been
revealed. Mouse macrophages have to be primed in order to
induce pro-IL-1b production, whereas in human macrophages the
dying autophagic MCF-7 cells could both up-regulate the
expression of the inflammasome system and activate it in the
absence of a priming signal. In our current study, we have shown
that different types of primed mouse primary macrophages
(resident, bone marrow-derived and elicited) can respond by IL-
1b release to dying autophagic Ba/F3 cells. We also showed in an
in vivo mouse model the pro-inflammatory characteristics of dying
autophagic Ba/F3 cells. Furthermore, unlike the autophagic
MCF-7 cells that die due to induction of autophagy after
starvation and tamoxifen treatment [40], IL-3 depleted Ba/F3
cells are not killed but only sensitized for apoptosis by autophagy.
Finally, we have shown in both our previous and current studies
that released ATP leading to purinergic receptor activation and
subsequent K+ efflux induces NALP3 inflammasome activation in
both human monocyte-derived macrophages and primed perito-
neal mouse macrophages. However, ATP was released from
human monocyte-derived macrophages during phagocytosis of
autophagic dying MCF-7 cells [17], whereas in our present study
we demonstrated that ATP was released from dying autophagic
cells, not from macrophages.
Figure 5. Uptake of dying autophagic cells leads to NALP3 and caspase-1 mediated IL-1b release in macrophages. Primed
thioglycollate-elicited macrophages from wild type and from CASPASE-1 (A) or NALP3 (C) knockout mice were co-incubated with IL-3-depleted cells.
ATP was used as a positive control. (B) Resident macrophages treated with Z-YVAD-fmk (specific caspase-1 inhibitor) were co-incubated with IL-3-
depleted dying cells. (D) Wild type and NALP3 or CASPASE-1 deficient macrophages were co-incubated with IL-3 depleted dying autophagic (AU) and
living Ba/F3 cells and phagocytosis was measured by flow cytometry. In parts A, B and C, control cells are primed macrophages but not incubated
with any type of Ba/F3 cells. Data represent the mean 6 SEM of two independent experiments for part A, three independent experiments for part B,
one experiment for part C, and two independent experiments for part D; all experiments were performed in triplicates, (***p,0.001).
doi:10.1371/journal.pone.0040069.g005
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Apoptotic cell death is induced in Ba/F3 cells by the cleavage of
the autophagy protein, beclin-1, which leads to release of
cytochrome c from mitochondria during IL-3 depletion [30].
Indeed, it has been shown [30] that at the onset of apoptosis, about
6 h after IL-3 withdrawal, it is not the high autophagy rate that
kills the cells. When MCF-7 or Ba/F3 cells die by apoptosis,
necrosis or necroptosis, their engulfment does not lead to
inflammasome activation. This indicates that only cells dying with
autophagic features due to growth factor depletion lead to
inflammasome activation in macrophages. Though 3-MA is
a non-specific chemical inhibitor for autophagy we can see the
decrease in IL-1b release from macrophages which is co-incubated
with autophagy inhibited dying cells. Of note, doxorubicin-treated
apoptotic Ba/F3 cells could not induce inflammasome activation
probably because they died by apoptosis without up-regulating
autophagy. On the other hand, it has been shown that
Figure 6. Analysis of upstream mechanisms of NALP3 inflammasome activation in peritoneal macrophages engulfing dying
autophagic cells. (A) Primed resident macrophages were co-incubated with dying autophagic (AU) cells in the presence of KCl. Macrophages were
treated with adenosine diphosphatase (apyrase) (B) and purinergic receptor inhibitor (KN-62) (C), or pannexin-1 channel inhibitor (CBX) (D) and co-
incubated with IL-3-depleted dying autophagic cells. (B, D) ATP concentrations in culture media, (E) ATP concentrations in conditioned medium (CM)
collected from Ba/F3 cells after 6 h of IL-3 depletion and CBX treated/non-treated dying AU cells (without macrophages). In parts A, B, C and D,
control cells are primed macrophages but not co-incubated with any type of Ba/F3 cells. Data represent the mean 6 SEM of pooled data from three
experiments for A, two experiments for B, four experiments for C and D, and three experiments for E; experiments were performed in triplicates;
(**p,0.01,**** p,0.0001).
doi:10.1371/journal.pone.0040069.g006
Inflammasome Activation by Dying Autophagic Cells
PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e40069
doxorubicin induces immunogenic cell death in cancer cells
through the calreticulin exposure pathway as well as inflamma-
some activation in the phagocytic cells [41]. In our previous work,
knocking down calreticulin in autophagic dying cells did not
prevent inflammasome activation in macrophages taking up these
cells [17]. Another recent study demonstrated that doxorubicin-
induced immunogenic apoptotic cells can be recognized and
responded to by the TLR-2/TLR-9-Myeloid differentiation
primary response gene (88) (Myd88) signaling pathway; this
finding provides an alternative explanation for their pro-in-
flammatory effect [11].
It was recently shown that accumulation of autophagic vacuoles
in glioblastoma cell lines following treatment with a lysosome
inhibitor [42] results in a sustained imbalance: the rate of
autophagic vacuole formation exceeds the rate of autophagic
vacuole degradation and promotes development of autophagic
stress predisposing to neuronal and glial cell death [43]. In our
current study, we checked whether dying autophagic Ba/F3 cells
with autophagic stress due to autophagosome accumulation can
also lead to an inflammatory response in macrophages. Autopha-
gosome accumulation by itself, induced by CQ treatment in the
presence of IL-3, did not induce cell death and was not sufficient
to cause caspase-1 activation when these cells were engulfed. Even
increased autophagy in dying cells, which can occur, for example,
during surface detachment or anoikis in MCF-7 cells [40], does
not induce inflammasome activation [17]. Therefore, it appears
that cell death of target cells has to be initiated by autophagy (or at
least autophagy has to sensitize cells for apoptosis) to create the
molecular pattern needed for inflammasome activation following
phagocytosis of these cells. This conclusion is supported by the
finding that a combination of IL-3 depletion and lysosomal
inhibitor treatment promotes higher rates of cell death and leads to
more efficient engulfment of dying cells and stronger induction of
the inflammasome activating pathway, together with the release of
more IL-1b from the engulfing macrophages.
Figure 7. Intraperitoneal injection of IL-3-depleted dying autophagic Ba/F3 cells induces a sterile inflammatory response
(neutrophil influx). Dying autophagic, apoptotic or necrotic cells and living cells were intraperitoneally injected into wild type BALB/c mice. Equal
volumes of D-PBS were injected in mice as negative controls. Peritoneal exudate cells (PECs) were collected 16 h later and monocytes, macrophages,
eosinophils and neutrophils were stained with anti-mouse antibodies F4/80-APC with CD11b-APC-Cy7 and Ly-6G-APC with CD11b-APC-Cy7 and
analyzed on BD LSR-II. Graphs represent the number of macrophages (F4/80high CD11bhigh), monocytes (F4/80medium CD11bhigh), eosinophils (F4/
80medium CD11bmedium) and neutrophils (CD11b+ Ly6Ghigh) in PECs after injection of AU, necrotic, living or apoptotic Ba/F3 cells. (***p,0.001,
****p,0.0001).
doi:10.1371/journal.pone.0040069.g007
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We have shown that IL-1b release from macrophages co-
incubated with dying autophagic cells is caspase-1 dependent by
using specific caspase-1 inhibition and caspase-1 deficient macro-
phages. We then checked whether the NALP-3 inflammasome
plays a role in this pro-inflammatory response. When we co-
incubated NALP-3 deficient macrophages with dying autophagic
cells, the released IL-1b was less than from control macrophages
but a lower level of inflammasome activation was still observed.
Even the known NALP-3 inducer ATP mediated IL1-b release
[23] from NALP-3 deficient macrophages was not completely
prevented either. Ultra-pure LPS priming of macrophages also led
to weaker inflammasome activation in the knockout macrophages.
We do not claim that only NALP-3 inflammasome can be
activated in macrophages while engulfing dying autophagic cells.
Inflammasome complexes other than NALP-3 might also be
activated by engulfed autophagic dying cells, especially in mice
developing in and compensating for the absence of NALP-3. It was
recently shown that there is cooperation between NLRP3 and
NLRC4 inflammasomes in vivo during S. typhimurium infection, and
that deficiency of either NLRP3 or NLRC4 does not change the
bacterial infection in the mice [44,45]. On the other hand,
caspase-1 activity in NLRP3-deficient obese mice decreases but is
not abolished in the presence of inflammasome inducers [44,46],
suggesting that inflammasome ‘‘priming’’ [47] plays a role at least
in the pathophysiology of obesity. Additionally, it is also known
that components of the NLRP1 and NLRC4 inflammasomes are
constitutively expressed in cells, whereas NLRP3 transcription is
triggered by bacterial components through the TLR4 pathway,
a process that is also called ‘‘priming’’ [47].
Classical apoptotic cells are strong inhibitors of the TLR-
mediated, NF-kB dependent inflammatory response of macro-
phages [7]. Accordingly, as we demonstrate here, dying
autophagic Ba/F3 cells can also inhibit LPS-triggered IL-6
secretion. This well known anti-inflammatory effect of apoptotic
cells is mediated by cell surface interactions and does not require
phagocytosis of dying cells [7]. We found that dying autophagic
Ba/F3 cells had to be internalized by macrophages to induce
inflammasome activation and IL-1b release, which do not
depend on the NF-kB pathway. The engulfed dying autophagic
cells had to initiate an intracellular signaling pathway to induce
inflammasome activation and exert pro-inflammatory effects. It is
not clear how the engulfment process and/or the specific
components of the dying autophagic cells sensitize macrophages
for the ATP-dependent NALP3 activation.
Several mechanisms that are not mutually exclusive have been
proposed to explain how NALP3 inflammasomes are activated.
Direct interaction between NALP3 and its activators has been
shown only in a few cases. For instance, bacterial muramyl
dipeptide (MDP) and bacterial cell wall peptidoglycans interact
directly with the leucine-rich repeat (LRR) part of NALP1 and
NALP3, respectively [48]. However, NALP3 inflammasome
activation pathways have not been defined for most pathogen-
associated molecular patterns (PAMPs) and DAMPs, and it is
unlikely that the different activators are specifically sensed by the
inflammasome. One of the general mechanisms of inflammasome
activation involves extracellular ATP, which generates an activa-
tion signal via the purinergic P2X7 receptors, followed by rapid K
+
efflux leading to low intracellular K+ levels. AT-mediated
activation of P2X7 can trigger K
+ efflux from the cytosol [49].
Physiologic concentrations of intracellular K+ can prevent
inflammasome assembly, and monosodium urate crystals can lead
to inflammasome activation by causing K+ efflux from macro-
phages. Based on these observations, it has been proposed that
a lowered K+ concentration in the cell is a common trigger of
inflammasome activation [26]. Here, we demonstrate that this also
takes place when dying autophagic cells are taken up by
macrophages. In our experiments, inflammasome activation by
dying autophagic cells could be suppressed by incubating
macrophages with dying cells in a medium containing a high
concentration of K+, which prevents K+ efflux. Inhibition of K+
efflux also decreased the basal levels of IL-1b released from ultra-
pure LPS pre-treated macrophages. Thus, during recognition and
engulfment of dying autophagic cells by macrophages, ATP
released in the extracellular space might initiate the above-
described sequence of events. Indeed, we found that a substantial
amount of ATP was released during co-incubation of dying cells
with macrophages. Hydrolyzing ATP by apyrase or blocking the
P2X7 receptor by a specific antagonist during phagocytosis of dead
cells significantly reduced IL-1b secretion. ATP is a known
NALP3 agonist, and different PAMPs and DAMPs have been
shown to lead to ATP release from monocytes followed by
autocrine stimulation of purinergic receptors such as P2X7 [35].
ATP released from dying tumor cells acts on P2X7 purinergic
receptors of dendritic cells, which can lead to inflammasome
activation and further IL-1b secretion [20]. It was recently shown
that certain types of necrotic cells can also release ATP and
activate the NALP3 inflammasome in engulfing macrophages
[50]. In our experiments, necrostatin-1 treatment of dying Ba/F3
cells did not prevent inflammasome activation during engulfment.
This shows that necroptosis was not involved in this pro-
inflammatory cell death process.
Blocking pannexin-1 channels during co-incubation of macro-
phages with dying autophagic cells led to inhibition of ATP release
and inflammasome activation, which indicates that this channel
was involved in ATP secretion. When we used Ba/F3 cells dying
due to the absence of IL-3 but in the presence of serum, we could
not detect ATP in the conditioned medium. However, ATP was
secreted from the dying cells while they were incubated in the
absence of macrophages and serum and this could be inhibited by
the pannexin-1 channel blocker. This is in line with other studies
Figure 8. Crude LPS-induced IL-6 release from macrophages is
inhibited by dying autophagic cells. Thioglycollate-elicited perito-
neal macrophages pre-treated with crude LPS were co-incubated with
IL-3-depleted dying autophagic (AU) cells or with doxorubicin treated
apoptotic cells. Data represent the mean 6 SEM of pooled data from
one experiment performed in five replicates; (****p,0.0001).
doi:10.1371/journal.pone.0040069.g008
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in different model systems. The pannexin-1 channel was identified
as a plasma membrane channel mediating the regulated release of
ATP and UTP (both are ‘‘find me’’ signals for phagocytes) from
apoptotic cells; activation of pannexin-1 is caspase 3 dependent
[51]. It was recently shown that the autophagy-dependent release
of ATP from dying tumor cells treated with anti-cancer agents
made these cells immunogenic [19]. It was reported that LPS-
treated peritoneal macrophages could release IL-1b in response to
ATP in a pannexin-1 channel dependent way [52]. Using short
hairpin (sh)RNA to silence pannexin-1 channels in neurons and
astrocytes, it was also demonstrated that pannexin-1 channels are
needed for inflammasome activation [53]. Inhibition of the
pannexin-1 channel in J774 macrophages showed that the
pannexin-1 pathway is essential for caspase-1 activation and
mature IL-1b release [29,36]. On the other hand, in macrophages
of pannexin-1 deficient mice, most of the known inflammasome
activators can elicit caspase-1 activation and IL-1bmaturation and
secretion [54], indicating that pannexin-1 is dispensable for the
assembly of caspase-1 mediated complexes. However, these mice
are deficient in ATP release from cells, including apoptotic cells,
and this deficiency is in line with several studies on various cell
types showing that this channel might be responsible for ATP
release [55].
We observed that 8–9 mM ATP is released from dying
autophagic Ba/F3 cells when they are incubated alone, but the
concentration of released ATP is only 0.4–0.6 mM during the co-
incubation of ultra-pure LPS primed macrophages with dying
autophagic Ba/F3 cells. It is possible that ecto-ATPases were
present in the medium during the co-incubation, which would
diminish the amount of ATP released from dying autophagic cells.
When we checked whether living, necrotic and apoptotic Ba/F3
cells release ATP, we observed that living cells did not release ATP
whereas necrotic and apoptotic cells secreted about 1 mM ATP
when they were not co-incubated with macrophages. Since
necrotic and apoptotic cells could not up-regulate IL-1b release
from macrophages, we assume that this small amount of ATP is
also neutralized by ecto-ATPases, preventing activation of the
purinergic receptors.
Treatment of cancer cells with anticancer chemicals (such as
oxiplatin and mitoxantrone) causes cancer cells to die in an
immunogenic manner [19]. It has been shown that dying cells are
autophagic and induce an immunogenic response in vivo by
recruiting dendritic cells and T cells into the tumor by releasing
ATP into the extracellular fluid [19]. The authors also indicated
that the immunogenicity of dying cells depends on autophagy
mediated release of ATP [19]. According to our results, both ATP
released from dying autophagic Ba/F3 cells and phagocytosis of
dying autophagic cells play a role in inflammasome activation in
macrophages. Furthermore, such an immunogenic response can
also be elicited when autophagy and cell death is induced by
cytokine depletion. When we treated Ba/F3 cells with doxorubi-
cin, which is also a known immunogenic anticancer drug, less ATP
was released than from autophagic dying cells, and this smaller
amount was not sufficient to induce inflammasome activation in
vitro. As we discussed above, this is likely due to ecto-ATPases and
raises the possibility that regulation of the intensity of autophagy
and thereby ATP release in dying tumor cells might be important
for achieving an effective immunogenic response in the host, like
the effect of increasing ATP levels in the tumor environment by
inhibiting ecto-ATPases [19].
Our in vivo results show that neutrophil influx (a sign of an acute
inflammatory response) was triggered by injection of dying
autophagic Ba/F3 cells in the peritoneal cavity of mice. Both
viable and necrotic Ba/F3 cells could recruit neutrophils into the
peritoneum, though to a lesser extent than autophagic dying ones.
It is very likely that injected ‘‘viable’’ cells start to die with
increased autophagy due to the lack of IL-3 cytokine in the
peritoneal cavity. Necrotic cells were frozen-thawed only once,
and residual intact cells cellular parts could have been destroyed in
the peritoneal cavity. Release of the contents of these newly
destroyed cells could recruit neutrophils and eosinophils to the
peritoneal cavity. Of note, doxorubicin-killed apoptotic Ba/F3
cells were the most potent inducers of neutrophil attraction in the
peritoneum. This is understandable because doxorubicin-treated
apoptotic cells have been shown to be the most potent inducers of
acute inflammation in vivo in several models. Injection of
doxorubicin into the peritoneal cavity of mice triggers a rapid
neutrophil influx that is associated with the apoptosis of
monocytes/macrophages [11]. Therefore, when doxorubicin-
killed cells are injected into the peritoneum, doxorubicin leaking
from the apoptotic cells might induce the death of peritoneal cells.
This effect can lead to the recruitment of immune cells to the
peritoneum (e.g. neutrophils) as shown by Krysko et al. [11].
Another study has shown that an immunogenic form of apoptosis
was induced by mitoxantrone, another prototype of anthracyclines
[10,56]. Stimulation of cancer cells with mitoxantrone results in
recruitment of dendritic cells and T lymphocytes to the site of the
tumor bed [19]. It has also been shown that this property of dying
cancer cells depends on their autophagic features, but this is not
relevant for our data because we have shown that apoptotic Ba/F3
cells treated with 10 mM doxorubicin do not exhibit autophagic
features. Therefore, it is likely that cells (autophagic dying cells or
apoptotic or necrotic cells) that we injected contained danger
signals independent of their dying status and that these signals
could induce an acute inflammatory response.
In summary, our findings point to mechanisms that lead to
NALP3 inflammasome activation in macrophages engulfing pro-
inflammatory dying autophagic cells. These findings contribute to
our understanding of how cancer cells can become immunogenic.
DAMPs exposed on dying autophagic cells and triggering
inflammasome activation inside macrophages have not been fully
clarified, and our future studies will focus on identifying the
molecular pattern associated with autophagic cells. That knowl-
edge might make it possible to therapeutically target autophagy in
cancer and other diseases.
Materials and Methods
Isolation of Macrophages
C57BL/6 mice, 6–9 weeks old, were used in all experiments
unless otherwise specified. Animals were maintained in the
pathogen-free animal facility of University of Debrecen (Debrecen,
Hungary) and at the Department for Molecular Biomedical
Research of Ghent University-VIB under the guidelines and
ethically approved protocols of Ghent University and VIB.
Peritoneal macrophages were obtained by peritoneal lavage from
mice that were either injected with 2 ml of 4% thioglycollate or
not injected. Thioglycollate-elicited peritoneal macrophages were
collected from the peritoneal cavity of mice three days after
injection. These macrophages were obtained from wild type and
from mice deficient in NALP3 (C57BL/6 background) or Caspase-1
(6x back crossed to C57Bl/6). For experiments with knockout
mice, wild type mice of appropriate background were used as
controls, and they were bred under the same animal house
conditions as the others. Macrophages from some mice were
pooled and cells were collected by centrifugation and plated in 96-
well plates (Corning, Lowell, MA) at 3x105 cells per well in RPMI-
1640 medium (Sigma, Steinheim, Germany) supplemented in 10%
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heat-inactivated fetal calf serum (FCS), 300 mg/L L-glutamine
(Sigma), 100 U/ml penicilline/0.1 mg/ml streptomycin (Sigma),
and 1 mM sodium pyruvate (Sigma). They were incubated at
37uC in an air atmosphere containing 5% CO2. Macrophages
were used for co-incubation experiments on the third day after
collection from the peritoneal cavity. Each day, unattached cells
were removed by refreshing the medium.
Bone marrow derived macrophages (BMDMs) were differenti-
ated from femoral bone marrow cells with 10% L929 conditioned
medium in RPMI medium (Sigma). Every other day, the medium
was replaced with the fresh medium. On the sixth day, cells were
collected with enzyme free cell dissociation buffer (Gibco,
Budapest, Hungary) and plated in a 96-well plate. They were
used for the co-incubation assay on the third day.
Induction of Different Types of Cell Death in Ba/F3 Cells
Ba/F3 cells are an IL-3-dependent pro-B cell line derived from
mouse bone marrow. It is an established cell line that is used in
Peter Vandenabeele’s Molecular Signalling and Cell Death Unit,
Department for Molecular Biomedical Research, VIB, Ghent,
Belgium. The same cell line was used also in the experiments
reported in [30]. Ba/F3 cells were grown in RPMI-1640
supplemented with 10% heat-inactivated FCS (Sigma), 10%
conditioned medium from WEHI-3B cells (a source of murine
IL-3), 300 mg/L L-glutamine (Sigma), 100 U/ml penicillin and
0.1 mg/ml streptomycin (Sigma), 400 mM sodium pyruvate
(Sigma), and 50 mM b-mercapto-ethanol (Sigma). They were
incubated at 37uC in a humidified air atmosphere containing 5%
CO2. All cell lines were Mycoplasma free. For cell death induction,
Ba/F3 cells were resuspended in fresh medium at 26104cells/ml,
and on the next day IL-3 was depleted for 6 h to induce
autophagic death. IL-3-depleted and non-depleted cells were
treated with chloroquine diphosphate (CQ-25 mM) (Fluka, Buchs
SG, Switzerland). Apoptotic cell death was induced by adding
10 mM doxorubicin (Sigma) for 16 h as described by Wirawan E.
et al. [30]. Different concentrations of doxorubicin were used to
optimize the apoptotic cell death conditions for Ba/F3 cells so that
autophagic activity was not induced. Necrotic cells were prepared
by freezing and thawing. After cells were thawed, they were
washed with PBS and used in the experiments. To block
necroptotic components, necrostatin-1 (Sigma) was used at
30 mM.
Cell Death Assay and Autophagy Detection by
Fluorescent Microscopy
Cell death was assessed by the Annexin-V fluorescein isothio-
cyanate Apoptosis Detection Kit (MBL, Budapest, Hungary)
according to manufacturer’s instructions. Propodium iodide (PI)
staining was used to determine plasma membrane permeability.
Percent of cells positive for Annexin-V or PI was determined on
a FACSCalibur flow cytometer (BD FACSCaliburTM flow
cytometer, Franklin Lakes, USA).
Autophagosome formation was visualized by fluorescent
microscopy (Axiovert-150 Zeiss, Budapest, Hungary) by staining
dying autophagic cells with anti-LC3 antibody and acridine
orange (Sigma) (1 mM, 20 min). For staining with LC-3 antibody
and visualization of autophagosomes living and IL-3 depleted Ba/
F3 cells, cytospins of Ba/F3 cells were fixed with 4% para-
formaldehyde in PBS for 15 min. Blocking was done with 5% BSA
(bovine serum albumin) in PBS + %0.1 Triton-X for 1 h. They
were then incubated with anti-LC3 polyclonal antibody (5 mg/ml,
Novus Biologicals, Cambridge, England) at room temperature for
2 h. Secondary antibody was Cy3-labeled goat anti-rabbit (Sigma)
and was used for 1 h. Nuclei were labeled with DAPI (Sigma) and
viewed with a fluorescent microscope (Axiovert-150 Zeiss,
Budapest, Hungary). Washings were done for 365 min with
PBS containing %0.1 Triton-X.
Immunoblot Analysis
The anti-LC3 polyclonal antibody mentioned above was also
used in immunoblot analysis. Equal amounts of proteins (17.5 mg)
obtained from cell lysates were separated on a NuPAGE 15% Bis-
Tris polyacrylamide gel (Invitrogen, Merelbeke, Belgium) and
transferred to an Immobilon-P membrane (Millipore, Budapest,
Hungary; pore size 0.45 mm). Membranes were blocked in Tris
buffered saline containing 0.05% Tween-20 (TBS-T) and 5% non-
fat dry milk (BioRad, Budapest, Hungary) for 1 h. After blocking,
membranes were probed overnight at 4uC with anti-LC3 poly-
clonal antibody (2 mg/ml; NovusBiologicals) and anti-actin poly-
clonal antibody (0.8 mg/ml) (Sigma) followed by incubation for 1 h
with a rabbit anti-rat peroxidase-conjugated secondary antibody
(Sigma) for 1 h at room temperature. Pro- and mature caspase 3
(1 mg/ml) were also checked by using caspase 3 antibody (BD
Pharmingen, Budapest, Hungary). Peroxidase activity was de-
tected with SuperSignal West Femto Maximum Sensitivity
Chemiluminescent Substrate (Pierce, Rockford, IL) using a Lumi-
Imager (Roche Diagnostics, Mannheim, Germany). Fermentas
pre-stained protein ladder was used as protein marker in each blot.
Blots in Figure 1B, 1D and 2A, we have not de-stripped the
membrane before detecting the actin protein and we have
developed the membrane with anti-actin antibody after the
washing steps upon developing it for anti-LC3. In Figure 2B and
4A, membranes were de-stripped (15-20 min), washed 3-4 X for
10 min with TBS-T and then re-blocked with 5% non-fat dry milk
in TBS-T solution for 1h at room temperature. Then membranes
were probed overnight with anti-actin first antibody, then the anti-
rabbit secondary antibody for 1 h at room temperature. Detection
of the peroxidase activity was done same as explained above.
Stripping solution contains 2% SDS, 100 mM beta-mercaptoetha-
nol and 50 mM TRIS, pH 6.8. The ratio of the integrated density
of LC3-II to actin was quantified by using Image J (NIH
Bethesda).
In vitro Phagocytosis Assay
Thioglycollate-elicited peritoneal macrophages, resident macro-
phages and BMDMs were collected and plated as described above.
They were primed with ultra-pure E. coli LPS (Invivogen,
Toulouse, France) (0.05 ng/ml for resident macrophages,
500 ng/ml for thioglycollate-elicited macrophages, 100 ng/ml
for BMDMs) 4 h before starting the phagocytosis assay. The ratio
of phagocytes (36105cells/well) to cells to be engulfed
(1.56106cells/well) was set at 1:5. Macrophages were labeled
with 5-(and-6)-(((4- chloromethyl)benzoyl)amino)tetramethylrho-
damine (CMTMR) (Invitrogen) (7.5 mM, 4 h) and dying cells
were stained with 5-(and-6)-carboxyfluorescein diacetate, succini-
midyl ester (CFDA) (Invitrogen) (17.5 mM, 6 h). The phagocytosis
assay was started when the cells to be engulfed were added to the
phagocytes and they were kept together for 2 h. After the
phagocytosis assay and following removal of non-engulfed dying
cells, macrophages were treated with trypsin at 37uC for 15 min to
remove attached cells so that only the macrophages engulfing
dying cells are quantified.
The net phagocytosis rate was always checked by FACS
analysis. Dying autophagic, apoptotic or necrotic cells and living
cells were fed to macrophages and co-incubated for 2 h. Addition
of 5 mM ATP (Sigma) was used as a positive control for IL-1b.
Living Ba/F3 cells were fed to macrophages in their complete
medium. When effect of inhibition of autophagy with 10 mM 3-
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methyladenine (Sigma) and effect of inhibition of necroptosis with
30 mM necrostatin-1 (Sigma) were investigated, they were added
to the cultures during the 6 h of IL-3 depletion. Inhibition of
phagocytosis was carried out by pre-treating the macrophages with
0.1 mM cytochalasin D (CytD) (Sigma) for 45 min at 37uC and
maintaining this treatment throughout the phagocytosis assay.
Studies on the role of P2X7R activation was carried with the ATP-
hydrolyzing apyrase (Sigma) (2.5 units/ml) and the P2X7 receptor
antagonist KN-62 (Sigma) (1 mM) (apyrase and KN-62 treatments
were done 45 min before and throughout the phagocytosis assay).
The role of the pannexin-1 channel in NALP3 activation was
checked by using carbenoxolone disodium salt (CBX) (Sigma)
(5 mM) 45 min before and throughout the phagocytosis assay.
Dying autophagic cells were also treated with CBX (5 mM).
Studies on the role of potassium efflux were carried out by using
medium containing 130 mM KCl (Sigma) during co-incubation.
Studies on how the specific caspase-1 inhibitor Z-YVAD-FMK
(BioVision Int, Brussels, Belgium) (50 mM) affects IL-1b pro-
duction were carried out by applying it 45 min before and
throughout the phagocytosis assay.
Measurement of IL-1b and ATP
LPS primed macrophages were co-incubated with appropriate
target cells and after the 2 h of co-incubation supernatants were
collected and IL-1b was measured by using ELISA (R&D DuoSet,
Budapest, Hungary). In experiments in which CASPASE-1/
NALP3 knockout mice macrophages were used, immunoreactive
levels of IL-1b were measured in conditioned medium by using
a Milliplex mouse cytokine kit (MPXMCYTO-70K-01, Merck
Millipore, Overijse, Belgium) according to the manufacturer’s
instructions and analyzed on a Bio-Plex 200 (Bio-Rad, Nazareth
Eke, Belgium).
The concentration of ATP was measured in supernatants by
using ATPliteTM Luminescence Assay System (Perkin Elmer,
Budapest, Hungary) according to the manufacturer’s instructions,
and light production was measured on a VICTOR2TM (Perkin
Elmer) reader.
Intraperitoneal Injection of Dying/dead Ba/F3 Cells and
Phenotyping of Peritoneal Exudate Cells
Autophagy, apoptosis and necrosis were induced in Ba/F3 cells
as described above. Dying autophagic, apoptotic or necrotic cells
and live cells were harvested by centrifugation, washed three times
with sterile D-PBS (Invitrogen) and resuspended in D-PBS at
a density of 406106 cells/ml. Balb/c mice syngeneic for Ba/F3
cells (8–10 weeks old, Janvier, Bio Services BV, The Netherlands,
n = 4-5 mice per group) were intraperitoneally injected with
106106 cells/mouse in 0.250 ml of D-PBS. Equal volumes of D-
PBS were injected as negative controls. Sixteen hours after
injection, animals were euthanized by CO2 exposure, and
peritoneal exudate cells (PECs) were isolated by peritoneal lavage.
The red blood cells were lysed with ACK cell lysis buffer (Lonza
Walkersville, Basel, Switzerland). The number of PECs was
counted in a hemocytometer using trypan blue and phenotyped by
flow cytometry. All experimental procedures were approved by the
local Ethics Committee of Ghent University–VIB.
Flow Cytometric Analysis of PECs Phenotypes
PECs (56105) were incubated with rat anti-mouse antibody
2.4G2 (BD Pharmingen, Erembodegem, Belgium) for 30 min at
4uC to block FccRIIB/III receptors. Since apoptotic cells were
treated with doxorubicin, which has a broad range of auto-
fluorescence, we divided each sample and used two different
stainings in order to identify monocytes, macrophages, eosino-
phils and neutrophils. To quantify monocytes, macrophages,
neutrophils and eosinophils, the PECs were stained with anti-
mouse antibodies F4/80-APC (clone BM8, eBioscience) and
CD11b-APC-Cy7 (clone M1/70, BD Pharmingen). To identify
neutrophils, the PECs were stained with anti-mouse antibodies
Ly-6G-APC (clone 1A8, BD Pharmingen) and CD11b-APC-Cy7
(clone M1/70, BD Pharmingen). All the stainings were done for
30 min at 4uC in PBS. Just before flow cytometric analysis on
BD LSR-II (BD Biosciences), 1.25 nM of Sytox Blue dead cell
stain was added (Invitrogen) to exclude dead cells from the
measurements. Data were acquired and analyzed by BD
FACSDiva software (BD Biosciences). The following cell
populations were discriminated: macrophages (F4/80high
CD11bhigh), monocytes (F4/80medium CD11bhigh), eosinophils
(F4/80medium CD11bmedium) and neutrophils (CD11b+ Ly6Ghigh).
To determine the number of cells in each specific cell population,
the total number of PECs was multiplied by the percentage of
specific cell population mentioned above.
Statistical Methods
Results are expressed as the mean 6 SEM for the number of
assays indicated. For multiple comparisons of groups statistical
significance was calculated and evaluated by one-way ANOVA
followed by Tukey post-hoc test. In comparison of two groups
non-bias two-tailed unpaired student t test was used.
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